Browsing Category

65215 posts
NETMARBLE OPENS GLOBAL PRE-REGISTRATION FOR UPCOMING ACTION RPG SOLO LEVELING:ARISE

NETMARBLE OPENS GLOBAL PRE-REGISTRATION FOR UPCOMING ACTION RPG SOLO LEVELING:ARISE

Early Access Available for Canadian Players Starting March 21 LOS ANGELES, March…
SparkMeter Achieves Compliance with Philippines' Energy Regulatory Commission to Bolster Grid Efforts

SparkMeter Achieves Compliance with Philippines' Energy Regulatory Commission to Bolster Grid Efforts

SparkMeter is set to bring smart grid monitoring and analytics capability to…
MiTAC and TYAN Present Cutting-Edge Server Solutions for Cloud Computing at CloudFest 2024

MiTAC and TYAN Present Cutting-Edge Server Solutions for Cloud Computing at CloudFest 2024

RUST, Germany, March 20, 2024 /PRNewswire/ — Today, the subsidiary of MiTAC…
Minesto welcomes enhanced cooperation between European Union and the Faroe Islands

Minesto welcomes enhanced cooperation between European Union and the Faroe Islands

GÖTEBORG, Sweden, March 19, 2024 /PRNewswire/ — Minesto, leading ocean energy developer,…
Golem Network and Gamerhash AI Join Forces to Provide GPU Resources to the AI Industry

Golem Network and Gamerhash AI Join Forces to Provide GPU Resources to the AI Industry

The partnership with Gamerhash addresses the growing demand for GPU resources in…
Global Leading Crypto Exchange BingX Makes Move Into Latin American Fiat-to-Crypto Payments

Global Leading Crypto Exchange BingX Makes Move Into Latin American Fiat-to-Crypto Payments

VILNIUS, Lithuania, March 19, 2024 /PRNewswire/ — In a significant step towards…
SATO NAMED AS A WINNER OF FAST COMPANY'S INNOVATION AWARD

SATO NAMED AS A WINNER OF FAST COMPANY'S INNOVATION AWARD

The award in the Social Good category recognises SATO’s relentless focus on…
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential

SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential

SHANGHAI, March 19, 2024 /PRNewswire/ — Mabwell (688062.SH), an innovative-driven biopharmaceutical company with entire…